A comparison of the data between Table 1 and Table 2 suggests that, in general, the studied bornyl derivatives exert a bifunctional multitarget effect with high significance; mainly, they decrease insulin resistance (five significant targets: PPARδ, FFAR1, PTPN1, FFAR4, and PPARα) and also have properties of incretin-mimetics (three significant targets: DPP4, GIPR, and GLP1R). This evidence concerns the gene PTPN1 and Insulin resistance.